Rockefeller Capital Management
GNOM icon

Rockefeller Capital Management’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Rockefeller Capital Management’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$136K Buy
3,107
+2
+0.1% +$93 ﹤0.01% 2700
2025
Q4 		$141K Hold
3,105
– – ﹤0.01% 2538
2025
Q3 		$121K Buy
+3,105
New +$112K ﹤0.01% 2501
2024
Q4 		– Sell
-4,547
Closed -$205K – 1679
2024
Q3 		$205K Buy
+4,547
New +$203K ﹤0.01% 1603
2023
Q3 		– Sell
-7,400
Closed -$359K – 1624
2023
Q2 		$359K Buy
+7,400
New +$370K ﹤0.01% 1463
2023
Q1 		– Sell
-2,300
Closed -$116K – 2758
2022
Q4 		$116K Buy
2,300
+373
+19% +$19.2K ﹤0.01% 1958
2022
Q3 		$96K Hold
1,927
– – ﹤0.01% 2014
2022
Q2 		$94K Sell
1,927
-448
-19% -$22.7K ﹤0.01% 1981
2022
Q1 		$142K Buy
2,375
+16
+0.7% +$1.01K ﹤0.01% 1832
2021
Q4 		$187K Hold
2,359
– – ﹤0.01% 1667
2021
Q3 		$208K Sell
2,359
-41
-2% -$3.84K ﹤0.01% 1573
2021
Q2 		$238K Buy
2,400
+800
+50% +$70.9K ﹤0.01% 1449
2021
Q1 		$143K Buy
1,600
+337
+27% +$33.3K ﹤0.01% 1453
2020
Q4 		$119K Buy
1,263
+1,113
+742% +$93.1K ﹤0.01% 1373
2020
Q3 		$10K Buy
+150
New +$10.7K ﹤0.01% 2009

Other funds holding GNOM

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $8.76B AUM 23.12% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
SWP
Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return
AA
Armis Advisers Atlanta, Georgia $1.09B AUM 22.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CFD
Creative Financial Designs Kokomo, Indiana $1.65B AUM 15.6% 1-Year Est. Return

Rockefeller Capital Management's GNOM Position: Q1 2026 in Review

Rockefeller Capital Management increased its Global X Genomics & Biotechnology ETF (GNOM) stake by 0.06% in Q1 2026, buying an estimated $93 and bringing the position to 3,107 shares worth $136K. The position accounts for ﹤0.01% of the portfolio, ranked #2700.

Rockefeller Capital Management first reported a position in GNOM in Q3 2020 and has held it in 15 quarters since. The position peaked at $359K in Q2 2023. 40 funds tracked by Wall St. Rank hold GNOM as of Q1 2026.

  • Rockefeller Capital Management held 3,107 shares of Global X Genomics & Biotechnology ETF worth $136K as of Q1 2026.
  • Rockefeller Capital Management bought 2 Global X Genomics & Biotechnology ETF shares in Q1 2026, an estimated $93.
  • Global X Genomics & Biotechnology ETF made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #2700 holding.
  • Rockefeller Capital Management first reported a position in Global X Genomics & Biotechnology ETF in Q3 2020 and has held it in 15 quarters since.
  • Rockefeller Capital Management's Global X Genomics & Biotechnology ETF position peaked at $359K in Q2 2023.
  • 40 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.